• 4 results in Exploration of Digestive Diseases
    Sort by
    Open Access
    Original Article
    Familial achalasia isolated or syndromic: about 18 families
    Aim: Familial achalasia (FA) is a very rare condition. This work aims to evaluate its prevalence, characterize its clinical profile in a large series, and assess the efficacy and safety of pneuma [...] Read more.
    Amar Tebaibia ... Nadia Oumnia
    Published: October 26, 2023 Explor Dig Dis. 2023;2:276–281
    DOI: https://doi.org/10.37349/edd.2023.00030
    This article belongs to the special issue Advances in Hepato-gastroenterology: Diagnosis, Prognostication, and Disease Stratification
    Times Cited: 0
    Open Access
    Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Non-alcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide, with a progressive form of non-alcoholic steatohepatitis (NASH). It may progress to advanced liver diseases, [...] Read more.
    Chunye Zhang ... Ming Yang
    Published: October 25, 2023 Explor Dig Dis. 2023;2:246–275
    DOI: https://doi.org/10.37349/edd.2023.00029
    This article belongs to the special issue Cellular and Molecular Targets for NAFLD or MAFLD Treatments and Their Functions in Liver Fibrosis, Cirrhosis, and Cancer
    Times Cited: 0
    Open Access
    Interplay of autophagy, apoptosis, and senescence in primary biliary cholangitis
    The pathogenesis of primary biliary cholangitis (PBC) is particularly complicated as both intrinsic and extrinsic factors are implicated. Several forms of cellular death, both programmable and non-p [...] Read more.
    Elias Kouroumalis ... Argyro Voumvouraki
    Published: October 16, 2023 Explor Dig Dis. 2023;2:223–245
    DOI: https://doi.org/10.37349/edd.2023.00028
    This article belongs to the special issue CHOLESTASIS
    Times Cited: 0
    Open Access
    Drug-induced cholestasis: causative agents and challenges in diagnosis and management
    Drug-induced liver injury (DILI) is an adverse reaction to drugs and other xenobiotics that can have serious consequences and jeopardise progress in pharmacological therapy. While DILI is predominan [...] Read more.
    Jose M. Pinazo-Bandera ... Miren García-Cortés
    Published: September 18, 2023 Explor Dig Dis. 2023;2:202–222
    DOI: https://doi.org/10.37349/edd.2023.00027
    This article belongs to the special issue CHOLESTASIS
    Times Cited: 0